{"id":843,"date":"2022-08-22T15:50:28","date_gmt":"2022-08-22T15:50:28","guid":{"rendered":"https:\/\/weblearnbd.net\/wp\/bioxlab\/?page_id=843"},"modified":"2025-03-26T12:06:42","modified_gmt":"2025-03-26T12:06:42","slug":"regulatory-pharmacovigilance","status":"publish","type":"page","link":"https:\/\/alfarmakos.com\/sq\/regulatory-pharmacovigilance\/","title":{"rendered":"\u00c7\u00ebshtje Rregullatore dhe Farmakovigjilenc\u00eb"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\r\n\t\t
\r\n SH\u00cbRBIMET TONA<\/span>\r\n \r\n

Sh\u00ebrbimi p\u00ebr \u00c7\u00ebshtjet rregullatore dhe Farmakovigjilenca<\/h2>\r\n <\/div>\r\n \r\n\t\t\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

N\u00eb Alfarmakos, Departamenti i \u00c7\u00ebshtjeve Rregullatore luan rol ky\u00e7 n\u00eb sigurimin e p\u00ebrputhshm\u00ebris\u00eb rregullatore p\u00ebr barnat, pajisjet mjek\u00ebsore, kozmetik\u00ebn dhe suplementet ushqimore. Ekipi yn\u00eb menaxhon n\u00eb m\u00ebnyr\u00eb efikase dhe t\u00eb sakt\u00eb procesin e regjistrimit p\u00ebr nj\u00eb gam\u00eb t\u00eb gjer\u00eb produktesh, duke siguruar p\u00ebrputhshm\u00ebrin\u00eb me plot\u00eb legislacionin lokal dhe at\u00eb europian.\n\nP\u00ebr m\u00eb tep\u00ebr, ata mbik\u00ebqyrin me kujdes ciklin e jet\u00ebs s\u00eb barnave, duke menaxhuar rinovimet dhe dor\u00ebzimin e variacioneve n\u00eb koh\u00eb p\u00ebr t\u00eb gjitha produktet e p\u00ebrfshira, duke garantuar k\u00ebshtu vazhdim\u00ebsin\u00eb dhe cil\u00ebsin\u00eb e furnizimit t\u00eb tyre. Sh\u00ebrbimi rregullator \u00ebsht\u00eb nj\u00eb pik\u00eb ky\u00e7e p\u00ebr mbajtjen e marr\u00ebdh\u00ebnieve midis partner\u00ebve dhe Agjencis\u00eb Komb\u00ebtare t\u00eb Barnave dhe Pajisjeve Mjek\u00ebsore (AKBPM) \/ Ministris\u00eb s\u00eb Sh\u00ebndet\u00ebsis\u00eb.<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

P\u00ebr ne, nj\u00eb nga detyrat kryesore \u00ebsht\u00eb t\u00eb ofrojm\u00eb pacient\u00ebve barna me cil\u00ebsi t\u00eb lart\u00eb, efektive dhe t\u00eb sigurta, p\u00ebrfitimet e t\u00eb cilave tejkalojn\u00eb rreziqet e mundshme.\n\nP\u00ebr t\u00eb monitoruar sigurin\u00eb dhe efektivitetin e barnave tona, kemi krijuar nj\u00eb departament t\u00eb t\u00eb Farmakovigjilenc\u00ebs. Kur zbulojm\u00eb efekte an\u00ebsore, specialist\u00ebt tan\u00eb k\u00ebrkojn\u00eb shkakun e shfaqjes s\u00eb tyre dhe gjithashtu b\u00ebjn\u00eb gjith\u00e7ka q\u00eb \u00ebsht\u00eb e nevojshme p\u00ebr t\u00eb minimizuar dhe parandaluar shfaqjen e efekteve an\u00ebsore n\u00eb t\u00eb ardhmen.\n\nNe do t\u00eb jemi mir\u00ebnjoh\u00ebs p\u00ebr \u00e7do informacion mbi ngjarjet e pad\u00ebshiruara, efektet an\u00ebsore ose munges\u00ebn e efikasitetit n\u00eb p\u00ebrdorimin e barnave.\n\nInformacioni i ofruar nga ju \u00ebsht\u00eb rrept\u00ebsisht konfidencial dhe nuk do t\u00eb zbulohet, p\u00ebrve\u00e7 rasteve t\u00eb p\u00ebrcaktuara me ligj. M\u00eb posht\u00eb \u00ebsht\u00eb nj\u00eb form\u00eb p\u00ebr raportimin e nj\u00eb efekti an\u00ebsor. T\u00eb gjitha fushat jan\u00eb t\u00eb detyrueshme; n\u00ebse ndonj\u00eb informacion nuk dihet nga ju, \u00ebsht\u00eb e nevojshme ta specifikoni at\u00eb n\u00eb fush\u00ebn p\u00ebrkat\u00ebse.<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t
  • \n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\tExpanding Partner Portfolios<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
  • \n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\tExpert Pharmacovigilance and Regulatory Services<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
  • \n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\tComprehensive Regulatory Support<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
  • \n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\tCommitment to Safety and Compliance<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\r\n\r\n
    \r\n
    \r\n
    \r\n
    \r\n
    \r\n Raporto<\/span>\r\n

    Raportoni Ngjarjet e Pad\u00ebshiruara<\/h2>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
    \r\n
    \r\n
    \r\n \u00c7do ngjarje e pad\u00ebshiruar q\u00eb ndodh gjat\u00eb p\u00ebrdorimit t\u00eb nj\u00eb produkti edhe ato t\u00eb listuara n\u00eb fletudh\u00eb zuesen e pakos, duhet te raportohen. N\u00ebse hasni efekte an\u00ebsore, ju lutemi kontaktoni ekipin ton\u00eb t\u00eb farmakovigjilenc\u00ebs duke p\u00ebrdorur t\u00eb dh\u00ebnat e kontaktit m\u00eb posht\u00eb.<\/span>\r\n \r\n
    \r\n \n
    \n

    <\/p>

      <\/ul><\/div>\n
      \n
      \n<\/fieldset>\n<\/span>\n\n <\/span>\n\n